The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,4,10-trioxa-7-azacyclohexadecane ID: ALA5284487
Chembl Id: CHEMBL5284487
Max Phase: Preclinical
Molecular Formula: C12H25NO3
Molecular Weight: 231.34
Associated Items:
Names and Identifiers Canonical SMILES: C1CCCOCCOCCNCCOCC1
Standard InChI: InChI=1S/C12H25NO3/c1-2-4-8-15-11-12-16-10-6-13-5-9-14-7-3-1/h13H,1-12H2
Standard InChI Key: REHPQBGJMYPSQY-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 231.34Molecular Weight (Monoisotopic): 231.1834AlogP: 1.20#Rotatable Bonds: ┄Polar Surface Area: 39.72Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.08CX LogP: 0.96CX LogD: -0.71Aromatic Rings: ┄Heavy Atoms: 16QED Weighted: 0.68Np Likeness Score: -0.30
References 1. Li X, Liao J, Jiang Z, Liu X, Chen S, He X, Zhu L, Duan X, Xu Z, Qi B, Guo X, Tong R, Shi J.. (2020) A concise review of recent advances in anti-heart failure targets and its small molecules inhibitors in recent years., 186 [PMID:31759729 ] [10.1016/j.ejmech.2019.111852 ]